Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
Huimin LiuYuxin LiFangyuan GaoPeipei MengHao YuTong WuYang ZhouYu-Yong JiangXian-Bo WangPublished in: Disease markers (2020)
Serum clusterin is a potential biomarker for HBV-ACLF which can be used to assess clinical severity and the short-term prognosis of patients with this disease and may help clinicians identify HBV-ACLF with greater specificity and improved prognostic accuracy than existing prognostic markers.